Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1764-1767

  Jun, Soo Youn ^a   Jung, Gi Mo ^a   Son, Jee Soo ^b   Yoon, Seong Jun ^a   Choi, Yun Jaie ^b   Kang, Sang Hyeon ^a  

^a INtRON Biotechnology Inc   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLUTAMIC ACID; GLUTAMINE; HISTIDINE; ISOLEUCINE; PHAGE ENDOLYSIN LYSK; PHAGE ENDOLYSIN SAL 1; UNCLASSIFIED DRUG; VALINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATION; ENZYME ACTIVITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS;

ANTI-BACTERIAL AGENTS; CELL WALL; ENDOPEPTIDASES; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 79953165373     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01097-10     Document Type: Article

References (30)

1. Andrews, J. M. 2001. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl. 1):5-16.
2. Becker, S. C., J. Foster-Frey, and D. M. Donovan. 2008. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbiol. Lett. 287:185-191.
3. Cheng, Q., D. Nelson, S. Zhu, and V. A. Fischetti. 2005. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob. Agents Chemother. 49:111-117.
4. Donovan, D. M., M. Lardeo, and J. Foster-Frey. 2006. Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin. FEMS Microbiol. Lett. 265:133-139.
5. Entenza, J. M., J. M. Loeffler, D. Grandgirard, V. A. Fischetti, and P. Moreillon. 2005. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob. Agents Chemother. 49:4789-4792.
6. Filatova, L. Y., S. C. Becker, D. M. Donovan, A. K. Gladilin, and N. L. Klyachko. 2010. LysK, the enzyme lysing Staphylococcus aureus cells: specific kinetic features and approaches towards stabilization. Biochimie 92:507-513.
7. Fischetti, V. A. 2003. Novel method to control pathogenic bacteria on human mucous membranes. Ann. N. Y. Acad. Sci. 987:207-214.
8. Gao, G., M. Orlova, M. M. Georgiadis, W. A. Hendrickson, and S. P. Goff. 1997. Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection. Pro. Natl. Acad. Sci. U. S. A. 94:407-411.
9. Graeff, R., C. Munshi, R. Aarhus, M. Johns, and H. C. Lee. 2001. A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities. J. Biol. Chem. 276:12169-12173.
10. Hanlon, G. W. 2007. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents 30:118-128.
11. Horgan, M., et al. 2009. Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl. Environ. Microbiol. 75:872-874.
12. Johnson, A. P., et al. 2001. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J. Antimicrob. Chemother. 48:143-144. (Pubitemid 32684742)
13. Kusuma, C. M., and J. F. Kokai-Kun. 2005. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3256-3263.
14. Le Loir, Y., F. Baron, and M. Gautier. 2003. Staphylococcus aureus and food poisoning. Genet. Mol. Res. 2:63-76.
15. Loeffler, J. M., D. Nelson, and V. A. Fischetti. 2001. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294:2170-2172.
16. Loeffler, J. M., S. Djurkovic, and V. A. Fischetti. 2003. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bateremia. Infect. Immun. 71:6199-6204.
17. Loessner, M. J. 2005. Bacteriophage endolysins-current state of research and applications. Curr. Opin. Microbiol. 8:480-487.
18. Melchior, M. B., H. Vaarkamp, and J. Fink-Gremmels. 2006. Biofilms: a role in recurrent mastitis infections? Vet. J. 171:398-407.
19. Navarre, W. W., H. Ton-That, K. F. Faull, and O. Schneewind. 1999. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage φ11. Identification of a D-alanyl-glycine endopeptidase activity. J. Biol. Chem. 274:15847-15856.
20. Nelson, D., L. Loomis, and V. A. Fischetti. 2001. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc. Natl. Acad. Sci. U. S. A. 98:4107-4112.
21. Obeso, J. M., B. Martínez, A. Rodríguez, and P. García. 2008. Lytic activity of the recombinant staphylococcal bacteriophage ΦH5 endolysin active against Staphylococcus aureus in milk. Int. J. Food Microbiol. 128:212-218.
22. O'Flaherty, S., et al. 2004. Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J. Bacteriol. 186:2862-2871. (Pubitemid 38525941)
23. O'Flaherty, S., A. Coffey, W. Meaney, G. F. Fitzgerald, and R. P. Ross. 2005. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J. Bacteriol. 187:7161-7164.
24. O'Gara, J. P., and H. Humphreys. 2001. Staphylococcus epidermidis biofilms: importance and implications. J. Med. Microbiol. 50:581-587.
25. Platko, J. V., et al. 1995. A single residue can modify target-binding affinity and activity of the functional domain of the Rho-subfamily GDP dissociation inhibitors. Proc. Natl. Acad. Sci. U. S. A. 92:2974-2975.
26. Rashel, M., et al. 2007. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage φMR11. J. Infect. Dis. 196:1237-1247.
27. Schuch, R., D. Nelson, and V. A. Fischetti. 2002. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418:884-889.
28. Sitaram, N., M. Chandy, V. N. Pillai, and R. Nagaraj. 1992. Change of glutamic acid to lysine in a 13-residue antibacterial and hemolytic peptide results in enhanced antibacterial activity without increase in hemolytic activity. Antimicrob. Agents Chemother. 36:2468-2472.
29. Son, J. S., et al. 2010. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. Appl. Microbiol. Biotechnol. 86:1439-1449.
30. Yoong, P., R. Schuch, D. Nelson, and V. A. Fischetti. 2004. Identification of a broadly active phage lytic enzyme with lethal activity against antibioticresistant Enterococcus faecalis and Enterococcus faecium. J. Bacteriol. 186: 4808-4812.